Nitric oxide does not act as a mediator coupling cerebral blood flow to neural activity following somatosensory stimuli in rats.

The possible role of nitric oxide (NO) on vibrissa-stimulated increase of regional cerebral cerebral blood flow (rCBF) and cerebral metabolic rate of glucose (rCMRglu) was investigated in conscious Wistar rats by using an inhibitor of NO synthase, NG-nitro-L-arginine (NOLAG) at a concentration of 30 mg/kg. In vivo autoradiography distribution with 14C-iodoantipyrine and 14C-deoxyglucose in two separate series showed CBF of 174% of control and CMRglu of 196% of control in the primary sensory cortex opposite the stimulated side in saline treated control animals. Similar increases were found in NOLAG-treated animals. Furthermore, NOLAG did not change either basal CMRglu or CMRO2. The findings suggest, that NO is not involved in coupling flow to the increased metabolism accompanying physiological sensory stimuli.

[1]  G. Edelman,et al.  The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Z Benyó,et al.  Effects of NG‐nitro‐L‐arginine and L‐arginine on regional cerebral blood flow in the cat. , 1992, The Journal of physiology.

[3]  Richard Graham Knowles,et al.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Pang,et al.  Pressor effect of NG-nitro-L-arginine in pentobarbital-anesthetized rats. , 1990, Life sciences.

[5]  K. Gale,et al.  Role of excitatory amino acid transmission in the genesis of seizures elicited from the deep prepiriform cortex , 1986, Brain Research.

[6]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Kato,et al.  Regional cerebral blood flow of the main visual pathways during photic stimulation of the retina in intact and split-brain monkeys. , 1974, Experimental neurology.

[8]  B. Meldrum,et al.  Anticonvulsant action of excitatory amino acid antagonists. , 1982, Science.

[9]  H. Toda,et al.  Halothane-induced relaxation of vascular smooth muscle: a possible contribution of increased cyclic GMP formation. , 1991, Japanese journal of pharmacology.

[10]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[11]  W. R. Webster,et al.  Autroradiographic demonstration with 2-[14C]deoxyglucose of frequency selectivity in the auditory system of cats under conditions of functional activity , 1978, Neuroscience Letters.

[12]  M. Reivich,et al.  Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C)deoxyglucose. , 1975, Science.

[13]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[14]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[15]  A. Gjedde,et al.  Rapid simultaneous determination of regional blood flow and blood-brain glucose transfer in brain of rat. , 1980, Acta physiologica Scandinavica.

[16]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[17]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[18]  S. Muldoon,et al.  Attenuation of Endothelium‐mediated Vasodilation by Halothane , 1988, Anesthesiology.